Next Article in Journal
Proteolytic Biosensors with Functional Nanomaterials: Current Approaches and Future Challenges
Next Article in Special Issue
Progress in the Optical Sensing of Cardiac Biomarkers
Previous Article in Journal
Two-Dimensional Transition Metal Dichalcogenide Based Biosensors: From Fundamentals to Healthcare Applications
Previous Article in Special Issue
Design and Engineering of a Palm-Sized Optical Immunosensing Device for the Detection of a Kidney Dysfunction Biomarker
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Detection of Advanced Glycosylation End Products in the Cornea Based on Molecular Fluorescence and Machine Learning

1
School of Life and Environmental Sciences, Guilin University of Electronic Technology, Guilin 541004, China
2
Guangxi Key Laboratory of Automatic Detecting Technology and Instruments, Guilin University of Electronic Technology, Guilin 541004, China
*
Author to whom correspondence should be addressed.
Biosensors 2023, 13(2), 170; https://doi.org/10.3390/bios13020170
Submission received: 10 October 2022 / Revised: 2 January 2023 / Accepted: 17 January 2023 / Published: 21 January 2023
(This article belongs to the Special Issue Trend in Optical Sensors for Medical Diagnostics and Therapeutics)

Abstract

:
Advanced glycosylation end products (AGEs) are continuously produced and accumulated in the bodies of diabetic patients. To effectively predict disease trends in diabetic patients, a corneal fluorescence detection device was designed based on the autofluorescence properties of AGEs, and corneal fluorescence measurements were performed on 83 volunteers. Multiple linear regression (MLR), extreme gradient boosting (XGBoost), support vector regression (SVR), and back-propagation neural network (BPNN) were used to predict the human AGE content. Physiological parameters which may affect corneal AGE content were collected for a correlation analysis to select the features that had a strong correlation with the corneal concentration of AGEs to participate in modeling. By comparing the predictive effects of the four models in the two cases of a single-input feature and a multi-input feature, it was found that the model with the single-input feature had a better predictive effect. In this case, corneal AGE content was predicted by a single-input SVR model, with the average error rate (AER), mean square error (MSE), and determination coefficient R-squared (R2) of the SVR model calculated as 2.43%, 0.026, and 0.932, respectively. These results proved the potential of our method and device for noninvasive detection of the concentration of AGEs in the cornea.

1. Introduction

An important reason for the production of advanced glycosylation end products (AGEs) is the long-term persistence of hyperglycemia in the human environment, when the persistent hyperglycemic state in the body accelerates the Maillard reaction between carbonyl compounds and amino compounds, eventually forming a class of end products that the body cannot metabolize [1,2,3]. AGEs increase slowly with age in normal subjects, while they accumulate dramatically in diabetic patients. Due to their nonmetabolizable properties, the concentration of AGEs in the human body can indirectly reflect the long-term glycemic control of diabetic patients [4,5]. Furthermore, the detection of AGEs can predict the probability of future diabetic complications in patients and provide a basis for assessing the degree of diabetes [6,7].
Currently, AGEs are mainly detected by methods such as the enzyme-linked immunosorbent assay (ELISA), chromatographic analysis, and the molecular fluorescence assay (MFA) [8,9]. Compared with ELISA, which is more widely used and more accurate, MFA has the advantage of being noninvasive and simple to perform [10].
The MFA method for the determination of AGEs is based on the fluorescent properties of AGEs and is achieved by fitting the relationship between the fluorescent intensity at a specific wavelength and the concentration of AGEs. Noninvasive detection of AGEs has become an important research direction in the biomedical field in recent years [11,12,13]. Hull et al. [14] developed a skin AGEs meter in which a certain bandwidth of ultraviolet (UV) light was applied to excite the skin, and thus the concentration of AGEs was measured by observing the intensity of autofluorescence. However, this method is not perfect. On the one hand, skin pigmentation severely affects the intensity of autofluorescence. On the other hand, the short period of metabolism makes it difficult to reflect the long-term accumulation level of AGEs. Van Best et al. [15] designed an instrument using a 460 nm excitation light source to measure corneal autofluorescence, demonstrating the existence of corneal fluorescence and the safety of the test. Compared with the device constructed by Van Best et al., our instrument adopted an optical fiber conductive structure that reduces the interference of light and uses excitation light at 370 nm. At the same time, our device has higher detection accuracy and conforms to the latest international standards, ensuring safety during measurement.
In this study, we aimed to measure autofluorescence in corneas with good optical properties and develop a prediction model for AGE content [16]. An instrument designed for determining the AGE content in corneas based on measurements of the fluorescence intensity measurement was successfully constructed. In addition, four commonly used algorithms, namely multiple linear regression (MLR), extreme gradient boosting (XGBoost) regression, support vector regression (SVR), and back-propagation neural network (BPNN), were used to develop regression models for predicting the content of AGEs. The functions in the sklearn library were used for training the model. The training set and test set were divided appropriately. The feasibility was experimentally verified.

2. Principles and Device

2.1. Principles of Fluorescence Quantification of AGEs

AGEs are compounds with multiple structures, and some of them have fluorescent properties. For example, pentosidine and tyrosine have strong fluorescence characteristics. The former are excited at approximately 335 nm and emit at 385 nm, and the latter are excited at 275 nm with a fluorescence emission peak at 300 nm. We chose to assay the concentration of glycosylated collagen, a substance that correlates with the total concentration of AGEs. The excitation wavelength of glycosylated collagen is 370 nm and the emission wavelength is 440 nm [17,18]. Therefore, the excitation light wavelength was 370 nm, and the emission wavelength at 440 nm was detected.
The intensity of fluorescence emitted by a fluorescent substance is proportional to its absorbed light intensity, as shown in Equation (1)
F = K I 0 I
where F represents the intensity of fluorescence emitted by the excitation of the fluorescent substance, I0 represents the incident intensity of the specific wavelength of the excitation light used when irradiating the fluorescent substance, I represents the transmitted light’s intensity after the excitation light irradiates the fluorescent substance, and K′ is the fluorescence quantum yield of the substance being tested [19].
According to the Lambert–Beer law, as shown in Equation (2):
I = I 0 10 ε b c
In the equation above, ε indicates the absorption coefficient of the fluorescent substance to the excitation light affected by the concentration of the substance and other factors, b indicates the distance passed when the excitation light irradiates the fluorescent substance, which is related to the thickness of the substance, and c indicates the concentration of the fluorescent substance in the solution. According to Equations (1) and (2), we obtained the following.
F = K I 0 1 10 ε b c = K I 0 1 e 2.303 ε b c
Assuming that the values of c and K = 2.303 K I 0 ε b c are small, when ε b c 0.05 , e 2.303 ε b c ≈ 1, Equation (3) can be reduced to:
F = 2.303 K I 0 ε b c = K c
In Equation (4), K = 2.303 K I 0 ε b is a constant and c is the concentration of the substance. From Equation (4), it can be seen that when c is small, c and F can achieve an ideal linear function, which means that once the fluorescence intensity has been measured, c can be determined. This relationship can be used as a basis for the quantitative analysis of fluorescent substances [20].

2.2. Composition of the System

We developed a portable fluorescence detection device to measure the autofluorescence in the cornea. The detection system mainly consists of a light source system, a fluorescence acquisition system, and a prediction system. The working process of the system is shown in Figure 1.

2.3. Corneal Fluorometry Device

In this study, we designed a corneal AGE detector based on human autofluorescence properties. The device is composed of two main parts: an excitation light source system and a fluorescence acquisition system. The micro control unit (MCU) controls the LED driver unit to generate a sTable 370 nm excitation light. The excitation light is coupled to a Y-type 12+1 fiber for transmission. The procedure of detection is to excite and collect the emitted fluorescence by irradiating the cornea, which is then detected using a Y-type 12+1 fiber coupled to a photoconverter. To reduce interference, narrow band filters were added to the excitation and emission light paths. A photoconverter with a high-sensitivity programmable photoelectric sensor was sourced from American Texas Advanced Optoelectronic Solutions (TAOS). To ensure the stable operation of the system, the system incorporated an independent temperature control unit and a high-power heat sink to ensure that the device was not affected by temperature variations. In order to maintain the optimal distance between the equipment and the eyes, the volunteers’ heads were fixed, and the distance between the optical fiber probe and the eyes was adjusted within a reasonable range. On the basis of these principles, the fluorescence intensity of the cornea under a specific wavelength of excitation light could be measured, and thus the AGE content could be inferred. A schematic diagram of the device is shown in Figure 2.
Figure 3 shows a physical diagram of the corneal fluorescence measurement device. It mainly consists of a Y-type 12+1 fiberoptic on the left-hand side and the main unit of the device on the right-hand side.

3. Methods and Feature Selection

3.1. Experimental Procedure

In this study, we recruited 83 volunteers from a hospital in Ganzhou City, including 67 volunteers with Type 2 diabetes. There were 39 males and 28 females in the diseased group, and 8 males and 8 females in the healthy group. All volunteers were informed about the experiment and the possible risks they faced. The experiments met the ethical standards and were conducted after the volunteers signed an informed consent form.
The steps of the experiment were as follows. Each volunteer was tested in the morning on an empty stomach, and physiological data such as height, weight, duration of illness, blood pressure, heart rate, fasting blood glucose (GLU), and glycated hemoglobin (HbA1c) were obtained from the volunteers with the help of medical personnel. After each volunteer in the hospital had their blood sample drawn, they were placed in a darkened space to avoid disturbance from environmental factors. Before starting the measurement, the volunteer was asked to sit comfortably in a chair and wait for a stable state so we could perform the corneal fluorescence measurement using the corneal fluorescence measurement device. When the excitation light source was relatively stable, the process of collecting the data on the AGEs’ fluorescence intensity in the corneas was started. Patients were tested three times separately, with a 5-min interval between each test. Three consecutive measurements were taken for a single test and averaged, with the final result being the results of the three tests averaged again. In addition, ELISA kits (96T, Jiubang Bio, China) were used to measure AGEs in volunteers’ sera separately in the hospital’s laboratory department. These professional operations were performed by medical personnel. The physiological parameters and the data on the fluorescence intensity of corneal AGEs are shown in Table 1.

3.2. Selection of Features

The alternative modeling parameters were professionally tested in the hospital, and the collected alternative modeling parameters (weight, age, duration of disease, blood pressure, heart rate, HbA1c, GLU, and corneal AGEs’ fluorescence intensity values) were analyzed for correlation. Pearson’s correlation coefficient was used to calculate the correlation matrix of the data, and a heat map of the data correlation analysis was drawn to easily see the correlation of the data, as shown in Figure 4. In Figure 4, we can easily see that the concentration of corneal AGEs was strongly correlated with corneal AGEs’ fluorescence intensity values; moderately correlated with the duration of the disease, GLU, and HbA1c; weakly correlated with age and BMI; and not correlated with blood pressure and heart rate. The weakly correlated features did not improve the accuracy of the model. Since the feature of corneal AGEs’ fluorescence intensity value had a strong correlation with the target and with three features (duration of the disease, HbA1c, and fasting GLU), we decided to use the four input features of corneal AGEs’ fluorescence intensity, duration of the disease, HbA1c, and fasting GLU for further modeling.
For the processing of the missing values of the input features, since the samples collected from the experiments in this study were only missing the disease duration for three patients, the average of the remaining data of this feature was taken for filling the missing data to ensure the sample size and data reliability [21].

4. Machine Learning Model for Predicting the Level of AGEs

4.1. MLR Model

MLR is a method of data analysis that looks for the intrinsic links that exist between variables [22]. For the experiments in this study, the functional relationships for the cases with a single input and with four inputs are as follows:
f 1 x = a 1 x 1 + c
f 4 x = b 1 x 1 + b 2 x 2 + b 3 x 3 + b 4 x 4 + c *
where x1, x2, x3, and x4 represent the four features of corneal AGEs’ fluorescence intensity, disease duration, GLU, and HbA1c, respectively; a1 is the feature coefficient of the single-input feature model; b1b4 are the individual feature coefficients of the four-input feature model; c and c* are the intercept terms of both; and f1(x) and f4(x) represent the concentration of corneal AGEs. A general diagram of the four-input feature model is shown in Figure 5.

4.2. XGBoost Regression Model

XGBoost is a tree-based integration algorithm proposed by Chen et al. [23]. It models by using multiple learners and has higher accuracy than a single learner. XGBoost uses the idea of boosting, which generates subtrees in a parallel manner, and finally sums up the predictions of multiple decision trees to obtain the final prediction result. It is different from the gradient boosting decision tree (GBDT) algorithm, which also uses the idea of boosting. In GBDT, each time the next weak learner is generated, the gradient of the loss function is used as the learning target, which is equivalent to optimizing with the gradient descent to approximate the minimum of the loss function, even if the loss function is zero and the final learner is as close to the true result as possible [24,25]. However, in XGBoost, the difference of the second-order Taylor expansion of the loss function was taken as the learning objective, which is equivalent to using Newton’s method of optimization to approximate the minimum of the loss function, which means making the loss function equal to zero. The model’s structure can be represented as follows:
y ^ = l L f x j , f l F
where y ^ is the final prediction of the model, L denotes the number of combined decision trees as the number of trees to be reconciled, fl is the lth tree, xj means the jth input sample, and F means the set of all tree models. The objective function and canonical terms used in the model are as follows:
O b j t = j = 1 n l o s s y j ^ t 1 , y j + f t x j + Ω f t
In Equation (8), l o s s y j ^ t 1 , y j + f t x j is the loss function, Ω f t is the canonical term, Ω f t = γ T + 1 2 λ i = 0 T w 0 2 . T is the number of leaf nodes, w j is the output of leaf node j, λ is the number of leaf nodes, and γ is the regularization parameter of the output. The model structure can be represented as shown in Figure 6.

4.3. SVR Model

Support Vector Machine (SVM) is a machine learning algorithm that determines the values of the parameters w and b by training the model on samples to finally obtain a regression function of the form f x = ω T x + b [26]. In this experiment, for the nonlinear data, the samples first need to be linearly separated in a higher-dimensional space by nonlinear mapping. At this point, the computational volume will be explosive, and a kernel function needs to be introduced to reduce the computational complexity [27]. With the introduction of the kernel function, the SVM’s nonlinear fitting function is as follows:
f x = ω T x + b = i = 1 n a i a i * K x i , x j + b
where K x i , x j is the kernel function, which represents the inner product operation of the mapping results of the input eigenvalues of the samples i and j; a i and a i * are Lagrangian multipliers.
SVR is an important application branch of SVM and is a model of SVM applied to regression problems. Moreover, the SVR model has many variants based on different kernel functions [28]. Since the problem to be solved in this study had no previous research to refer to, after several attempts, we finally selected the Gaussian kernel function with the best results for the prediction of the model. The comparison results of the kernel functions we adopted are shown in Table 2.

4.4. BPNN

The BPNN is divided into two propagation processes: forward and reverse. To avoid overfitting due to excessive complexity, a single implicit layer was used and the number of nodes in the implicit layer was set to 8 through several experiments. Adam was chosen as the optimizer and 3-fold cross-validation was used. The grid search function GridSearchCV was used to optimize the super-parameters of the model. The hidden layer used Tansigs-type functions and the model was trained using the Levenberg–Marquardt back-propagation algorithm [29,30]. After the forward propagation of each input to the output layer, the error back-propagation training corrected the weights and thresholds. The weights and thresholds were adjusted in several iterations until the errors were within the set requirements [31].
An overall representation of the BPNN model is shown in Figure 7.

5. Results and Analysis

Single-input features and four-input features were added into the four modeling algorithms, and the two datasets were randomly divided into a training set and a test set at the ratio of 7:3, with 58 samples in the training set and 25 samples in the test set. Table 3 shows a comparison of the single-input and four-input prediction effects of the four models. The deviation between the real value and the model’s predicted value, and the goodness of the model’s predictive effect, were used as evaluation indices to investigate the mean square error (MSE) and the coefficient of determination (R2) of the final results. The predictions using single-input features in this dataset were better than those with four-input features, indicating that the introduction of the three selected features would add noise effects to the model [32]. This is mainly because the correlation between AGEs’ fluorescence intensity and the concentration of corneal AGEs is too high. Therefore, the final results of these four quantitative prediction models with single-input features were compared and analyzed next.
With a single-input feature, the MLR prediction model had the highest average error rate (AER) of 2.96%, while the SVR prediction model had the lowest AER of 2.43%. In addition, SVR had the best performance for both MSE and R-squared (R2).
Figure 8 shows a comparison of the predictions for the single-input case, and it can be intuitively seen that the predictions of SVR were closest to the true values. In summary, the SVR prediction model had better predictions in this work and was more suitable for modeling this dataset.

6. Conclusions

In this study, we designed a device to measure corneal AGEs based on the fluorescent properties of AGEs. To build an effective regression model to measure the concentration of human AGEs, we tested the performance of four machine learning models (SVR, BP, XGBoost, and MLR). Furthermore, we recruited 83 volunteers for clinical trials to obtain real data. The experimental results showed that the predictive effects of the model with a single-input feature were better than those with four inputs because the three features of disease duration, HbA1c, and GLU added noise to the model. In conclusion, the SVR prediction model had the best predictions among the four models developed with this dataset. With the SVR model, an AER of 2.43%, an MSE of 0.026, and an R2 of 0.932 were obtained.
In further research, the range of test points should be widened to obtain a larger sample to improve the reliability of the test. In addition, the modeling algorithms used in this study all have hyperparameters that need to be set artificially, so heuristic parameter search methods, such as genetic algorithms and Particle Swarm Optimization, could be tried in future studies to perform global optimization in a larger search range to find the best prediction of the model. The portable fluorometer constructed in this study for the detection of AGEs provides a convenient method of immediate detection and has long-term monitoring potential for diabetic patients and pre-diabetic populations.

Author Contributions

Conceptualization and methodology, J.Z. and S.L.; software, H.Z.; validation and formal analysis, R.S. and Z.X.; writing—original draft preparation, S.L.; writing—review and editing, J.Z. and H.L.; funding acquisition, J.Z. and H.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (grant number 62263008); the Guangxi Natural Science Foundation of China (grant number 2022GXNSFAA035507); Guangxi Key Laboratory of Automatic Detecting Technology and Instruments; the 2019 Guangxi One Thousand Young and Middle-Aged College and University Backbone Teachers Cultivation Program; and the Guangxi Colleges and Universities Key Laboratory of Biomedical Sensors and Intelligent Instruments.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Biomedical Ethics Committee of Guilin University of Electronic Technology (QX2021-003, 10 July 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The source codes related to the present work can be found at: https://github.com/23Air/algorithnm.git (accessed on 9 December 2022).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chaudhuri, J.; Bains, Y.; Guha, S.; Kahn, A.; Hall, D.; Bose, N.; Gugliucci, A.; Kapahi, P. The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality. Cell Metab. 2018, 28, 337–352. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Lin, J.-A.; Wu, C.-H.; Yen, G.-C. Perspective of advanced glycation end products on human health. J. Agric. Food Chem. 2018, 66, 2065–2070. [Google Scholar] [CrossRef] [PubMed]
  3. Steenbeke, M.; De Bruyne, S.; Van Aken, E.; Glorieux, G.; Van Biesen, W.; Himpe, J.; De Meester, G.; Speeckaert, M.; Delanghe, J. UV Fluorescence-Based Determination of Urinary Advanced Glycation End Products in Patients with Chronic Kidney Disease. Diagnostics 2020, 10, 34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Kuzan, A. Toxicity of advanced glycation end products. Biomed. Rep. 2021, 14, 46. [Google Scholar] [CrossRef]
  5. Rhee, S.Y.; Kim, Y.S. The role of advanced glycation end products in diabetic vascular complications. Diabetes Metab. J. 2018, 42, 188–195. [Google Scholar] [CrossRef]
  6. Cepas, V.; Collino, M.; Mayo, J.C.; Sainz, R.M. Redox signaling and advanced glycation endproducts (AGEs) in diet-related diseases. Antioxidants 2020, 9, 142. [Google Scholar] [CrossRef] [Green Version]
  7. Beisswenger, P.J.; Howell, S.K.; Russell, G.; Miller, M.E.; Rich, S.S.; Mauer, M. Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation. Amino Acids 2014, 46, 311–319. [Google Scholar] [CrossRef]
  8. Akhter, F.; Chen, D.; Akhter, A.; Yan, S.F.; Yan, S.S. Age-dependent accumulation of dicarbonyls and advanced glycation endproducts (AGEs) associates with mitochondrial stress. Free Radic. Biol. Med. 2021, 164, 429–438. [Google Scholar] [CrossRef]
  9. Perrone, A.; Giovino, A.; Benny, J.; Martinelli, F. Advanced glycation end products (AGEs): Biochemistry, signaling, analytical methods, and epigenetic effects. Oxidative Med. Cell. Longev. 2020, 2020, 3818196. [Google Scholar] [CrossRef] [Green Version]
  10. Wei, Q.; Liu, T.; Sun, D.-W. Advanced glycation end-products (AGEs) in foods and their detecting techniques and methods: A review. Trends Food Sci. Tech. 2018, 82, 32–45. [Google Scholar] [CrossRef]
  11. Ninomiya, H.; Katakami, N.; Sato, I.; Osawa, S.; Yamamoto, Y.; Takahara, M.; Kawamori, D.; Matsuoka, T.-A.; Shimomura, I. Association between subclinical atherosclerosis markers and the level of accumulated advanced glycation end-products in the skin of patients with diabetes. J. Atheroscler. Thromb. 2018, 25, 1274–1284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Osawa, S.; Katakami, N.; Sato, I.; Ninomiya, H.; Omori, K.; Yamamoto, Y.; Takahara, M.; Miyashita, K.; Sakamoto, F.; Kawamori, D. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes. J. Diabetes Its Complicat. 2018, 32, 839–844. [Google Scholar] [CrossRef]
  13. Ashraf, J.M.; Ahmad, S.; Choi, I.; Ahmad, N.; Farhan, M.; Tatyana, G.; Shahab, U. Recent advances in detection of AGEs: Immunochemical, bioanalytical and biochemical approaches. IUBMB Life 2015, 67, 897–913. [Google Scholar] [CrossRef]
  14. Hull, E.; Ediger, M.; Unione, A.; Deemer, E.; Stroman, M.; Baynes, J. Noninvasive, optical detection of diabetes: Model studies with porcine skin. Opt. Express 2004, 12, 4496–4510. [Google Scholar] [CrossRef] [PubMed]
  15. Van Best, J.A.; Docchio, F. Simple, low-cost, portable corneal fluorometer for detection of the level of diabetic retinopathy. Appl. Opt. 1998, 37, 4303–4311. [Google Scholar] [CrossRef] [PubMed]
  16. Price, M.O.; Mehta, J.S.; Jurkunas, U.V.; Price, F.W., Jr. Corneal endothelial dysfunction: Evolving understanding and treatment options. Prog. Retin. Eye Res. 2021, 82, 100904. [Google Scholar] [CrossRef] [PubMed]
  17. Muir, R.; Forbes, S.; Birch, D.J.; Vyshemirsky, V.; Rolinski, O.J. Collagen glycation detected by its intrinsic fluorescence. J. Phys. Chem. B 2021, 125, 11058–11066. [Google Scholar] [CrossRef]
  18. Paolillo, F.R.; Mattos, V.S.; de Oliveira, A.O.; Guimarães, F.E.; Bagnato, V.S.; de Castro Neto, J.C. Noninvasive assessments of skin glycated proteins by fluorescence and Raman techniques in diabetics and nondiabetics. J. Biophotonics 2019, 12, e201800162. [Google Scholar] [CrossRef] [Green Version]
  19. Würth, C.; González, M.G.; Niessner, R.; Panne, U.; Haisch, C.; Genger, U.R. Determination of the absolute fluorescence quantum yield of rhodamine 6G with optical and photoacoustic methods–Providing the basis for fluorescence quantum yield standards. Talanta 2012, 90, 30–37. [Google Scholar] [CrossRef]
  20. Mauricio, F.G.M.; Silva, J.Y.R.; Talhavini, M.; Júnior, S.A.; Weber, I.T. Luminescent sensors for nitroaromatic compound detection: Investigation of mechanism and evaluation of suitability of using in screening test in forensics. Microchem. J. 2019, 150, 104037. [Google Scholar] [CrossRef]
  21. Nijman, S.; Leeuwenberg, A.; Beekers, I.; Verkouter, I.; Jacobs, J.; Bots, M.; Asselbergs, F.; Moons, K.; Debray, T. Missing data is poorly handled and reported in prediction model studies using machine learning: A literature review. J. Clin. Epidemiol. 2022, 142, 218–229. [Google Scholar] [CrossRef] [PubMed]
  22. Ali, M.; Prasad, R.; Xiang, Y.; Deo, R.C. Near real-time significant wave height forecasting with hybridized multiple linear regression algorithms. Renew. Sustain. Energy Rev. 2020, 132, 110003. [Google Scholar] [CrossRef]
  23. Chen, T.; Guestrin, C. Xgboost: A scalable tree boosting system. In Proceedings of the 22nd ACM Sigkdd International Conference on Knowledge Discovery and Data Mining, San Francisco, CA, USA, 3–17 August 2016; pp. 785–794. [Google Scholar]
  24. Bentéjac, C.; Csörgő, A.; Martínez-Muñoz, G. A comparative analysis of gradient boosting algorithms. Artif. Intell. Rev. 2021, 54, 1937–1967. [Google Scholar] [CrossRef]
  25. Zhang, Z.; Jung, C. GBDT-MO: Gradient-boosted decision trees for multiple outputs. IEEE Trans. Neural Netw. Learn. Syst. 2020, 32, 3156–3167. [Google Scholar] [CrossRef] [PubMed]
  26. Lu, J.; Yu, Z.; Zhu, Y.; Huang, S.; Luo, Q.; Zhang, S. Effect of lithium-slag in the performance of slag cement mortar based on least-squares support vector machine prediction. Materials 2019, 12, 1652. [Google Scholar] [CrossRef] [Green Version]
  27. Arumugam, P.; Jose, P. Efficient decision tree based data selection and support vector machine classification. Mater. Today Proc. 2018, 5, 1679–1685. [Google Scholar] [CrossRef]
  28. Da Silva Santos, C.E.; Sampaio, R.C.; dos Santos Coelho, L.; Bestard, G.A.; Llanos, C.H. Multi-objective adaptive differential evolution for SVM/SVR hyperparameters selection. Pattern Recognit. 2021, 110, 107649. [Google Scholar] [CrossRef]
  29. Pan, Y.; Wang, Y.; Zhou, P.; Yan, Y.; Guo, D. Activation functions selection for BP neural network model of ground surface roughness. J. Intell. Manuf. 2020, 31, 1825–1836. [Google Scholar] [CrossRef]
  30. Smith, J.S.; Wu, B.; Wilamowski, B.M. Neural network training with Levenberg–Marquardt and adaptable weight compression. IEEE Trans. Neural Netw. Learn. Syst. 2018, 30, 580–587. [Google Scholar] [CrossRef]
  31. Fei, J.; Wu, Z.; Sun, X.; Su, D.; Bao, X. Research on tunnel engineering monitoring technology based on BPNN neural network and MARS machine learning regression algorithm. Neural Comput. Appl. 2021, 33, 239–255. [Google Scholar] [CrossRef]
  32. Ibrahim, A.; Eltawil, A.; Na, Y.; El-Tawil, S. A machine learning approach for structural health monitoring using noisy data sets. IEEE Trans. Autom. Sci. Eng. 2019, 17, 900–908. [Google Scholar] [CrossRef]
Figure 1. Working process of the proposed device.
Figure 1. Working process of the proposed device.
Biosensors 13 00170 g001
Figure 2. Structure of the device.
Figure 2. Structure of the device.
Biosensors 13 00170 g002
Figure 3. Physical view of the corneal fluorescence measurement device.
Figure 3. Physical view of the corneal fluorescence measurement device.
Biosensors 13 00170 g003
Figure 4. Correlation matrix heatmap.
Figure 4. Correlation matrix heatmap.
Biosensors 13 00170 g004
Figure 5. The MLR model used for prediction.
Figure 5. The MLR model used for prediction.
Biosensors 13 00170 g005
Figure 6. The XGBoost model used for prediction.
Figure 6. The XGBoost model used for prediction.
Biosensors 13 00170 g006
Figure 7. The BPNN model used for prediction.
Figure 7. The BPNN model used for prediction.
Biosensors 13 00170 g007
Figure 8. Comparison of the predictions.
Figure 8. Comparison of the predictions.
Biosensors 13 00170 g008
Table 1. Physiological parameters and data on the fluorescence intensity of corneal AGEs.
Table 1. Physiological parameters and data on the fluorescence intensity of corneal AGEs.
ParametersDiabetic GroupHealthy Group
Age (years)53 ± 1544 ± 13
Height (cm)164.1 ± 6.5162.4 ± 6.1
Weight (kg)63.4 ± 7.256.7 ± 6.5
BMI (kg/m2)23.51 ± 2.1621.48 ± 1.72
Heart rate (beats/min)76 ± 1081 ± 8
Systolic pressure (mmHg)131.50 ± 12.61128.10 ± 6.62
Diastolic pressure (mmHg)79.82 ± 8.3080.10 ± 4.50
HbA1c (%)8.30 ± 1.965.08 ± 0.37
GLU (mmol/L)9.33 ± 2.275.25 ± 0.49
Fluorescence intensity of corneal AGEs 23.80 ± 2.1213.27 ± 1.65
Table 2. Model effects under different kernel functions.
Table 2. Model effects under different kernel functions.
KernelLinearPolyRbf
R 2 0.9260.9260.932
MSE0.0280.0280.026
Table 3. Comparison of the predictive effects.
Table 3. Comparison of the predictive effects.
Evaluation IndicesMLRXGBoostSVRBPNN
Single InputFour InputsSingle InputFour InputsSingle InputFour InputsSingle InputFour Inputs
MSE0.0270.0540.060.050 0.0260.065 0.02830.075
R20.9280.9000.9280.930 0.9320.808 0.9250.779
AER2.96%3.51%2.73%3.42%2.43%3.68%2.90%3.82%
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhu, J.; Lian, S.; Zhong, H.; Sun, R.; Xiao, Z.; Li, H. Detection of Advanced Glycosylation End Products in the Cornea Based on Molecular Fluorescence and Machine Learning. Biosensors 2023, 13, 170. https://doi.org/10.3390/bios13020170

AMA Style

Zhu J, Lian S, Zhong H, Sun R, Xiao Z, Li H. Detection of Advanced Glycosylation End Products in the Cornea Based on Molecular Fluorescence and Machine Learning. Biosensors. 2023; 13(2):170. https://doi.org/10.3390/bios13020170

Chicago/Turabian Style

Zhu, Jianming, Sifeng Lian, Haochen Zhong, Ruiyang Sun, Zhenbang Xiao, and Hua Li. 2023. "Detection of Advanced Glycosylation End Products in the Cornea Based on Molecular Fluorescence and Machine Learning" Biosensors 13, no. 2: 170. https://doi.org/10.3390/bios13020170

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop